Welcome to the DUMAS website!
DUal thrombolytic therapy with Mutant pro-urokinase and low dose Alteplase for ischemic Stroke
DUMAS is a phase II, randomized controlled trial in the Netherlands. This trial is initiated and coordinated by the Erasmus MC University Medical Center, Rotterdam.
DUMAS is designed to assess the safety and efficacy of dual thrombolytic treatment with mutant pro-urokinase and a low dose alteplase compared with usual treatment with alteplase alone for ischemic stroke.
The left hand menu helps you to navigate through this website and access more information about the trial.
The DUMAS executive committee
Diederik Dippel, Aad van der Lugt, Bob Roozenbeek, Nadinda van der Ende